Case of the Fortnight #1

Clinical history:

68-year-old male patient with rapidly growing swelling of 4 months duration. On the dorsal aspect of the forearm. O/e fairly well-circumscribed flesh-colored nodule., 2 x 1.8 cm. No history of other tumors in the body.

CASE OF THE FORTNIGHT Dr Gowripriya Consultant pathologist Dr Rela institute and medical center

MERKEL CELL CARCINOMA
  • 68 YEAR OLD MALE PATIENT WITH RAPIDLY GROWING SWELLING OF 4 MONTHS DURATION.
  • ON THE DORSAL ASPECT OF FOREARM.
  • O/E FAIRLY WELL CIRCUMSCRIBED FLESH COLOURED NODULE., 2 X 1.8 CM.
  • NO HISTORY OF OTHER TUMOURS IN THE BODY.

LEARNING POINTS:

  • 1)A rare, aggressive, primary cutaneous neuroendocrine carcinoma.
  • 2)Elderly males, sun exposed skin of head and neck/ extremities/ trunk
  • 3)Immunosuppression and advanced age are risk factors.v
  • 4)Cell of origin- unknown, possible precursors include Pro-B/ Pre-B lymphocytes, fibroblasts, dermal mesenchymal stem cells and epithelial cells.
  • 5) Clinically, rapidly growing violaceous/ flesh coloured nodules.
  • 6)Microscopy: Small blue round cell tumour in the dermis and/ or subcutis.
    • Cells with high nuclear: cytoplasmic ratio, salt and pepper chromatin.
    • Sheets/ nests/ occasional trabeculae/ pseudo-rosettes
    • Mitoses/ apoptosis/ necrosis.
    • Squamous differentiation maybe seen.
  • 7)Immunohistochemistry:
    • Neuroendocrine markers
    • CK 20- paranuclear dot- like positivity
    • Neurofilament
    • SAT B2
    • Often , Merkel Cell Polyoma Virus (see below)
  • 8)TWO MAJOR SUBSETS BASED ON VIRAL STATUS:
  • Feature MCPyV-positive MCPyV-negative (UV exposure related)
    Incidence More common Less common
    Morphology Pure Pure/ combined
    Prognosis Better Worse
    Tumor infiltrating
    lymphocytes
    Brisk Few
    IHC Rb pos (+++)
    P53 pos (+)
    P63 pos (+)
    Rb pos (+)
    P53 pos (+++)
    P63 pos (+++)
    Genetics Tumour mutational burden Tumour mutational burden
    low No Recurrent RB1/ P53 mutations No UV mutation signature high Recurrent RB1/ P53 mutations UV mutation signature
  • 9)Treatment: Excision, lymph node resections, Immune-checkpoint-inhibitors.
  • 10)Data for inclusion in pathology reports:
    • Maximum dimension of tumor (gross or microscopic)
    • Tumor confined to dermis/subcutis: yes/no
    • Involvement of underlying muscle, fascia, bone or cartilage: yes/no
    • Lymphovascular involvement: yes/no
    • Distance from surgical margin
    • Local microscopic “satellite” deposits of tumor: yes/no
    • Distance between main tumor and deep surgical margin
    • Morphology (pure neuroendocrine or combined): pure or combined
    • Merkel cell polyomavirus status: positive or negative
    • Immunohistchemical profile
    • P63 expression: positive or negative

REFERENCES:

1)Noreen M. Walsh, Lorenzo Cerroni; Merkel cell carcinoma: a review, Journal of cutaneous pathology https://doi.org/10.1111/cup.13910

2)WHO classifcation of skin tumours, 4th ed.